Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


30.12.2024

1 Acta Neuropathol
39 Alzheimers Dement
1 Biol Psychiatry
1 BMC Neurol
1 Brain Res
5 Curr Alzheimer Res
3 J Alzheimers Dis
1 J Neurochem
1 J Neurosci
1 Neurol Clin Pract
1 Neurology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. MOONEN S, Koper MJ, Van Schoor E, Schaeverbeke JM, et al
    Correction: Pyroptosis in Alzheimer's disease: cell type?specific activation in microglia, astrocytes and neurons.
    Acta Neuropathol. 2024;149:3.
    PubMed        


    Alzheimers Dement

  2. PRAKASH RS, McKenna MR, Gbadeyan O, Shankar AR, et al
    A whole-brain functional connectivity model of Alzheimer's disease pathology.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14349.
    PubMed         Abstract available

  3. MOHAMMAD A, Finch MS, Rouhana S, Mashouri P, et al
    Accelerated ovarian failure results in brain alterations related to Alzheimer's disease that are not recovered by high-intensity interval training in mice.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14463.
    PubMed         Abstract available

  4. KHALAFI M, Dartora WJ, McIntire LBJ, Butler TA, et al
    Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14458.
    PubMed         Abstract available

  5. BRATCHES RWR, Backhouse T, Barr PJ, Lee C, et al
    Factors associated with care-resistant behavior in the National Alzheimer's Coordinating Center's Uniform Data Set.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14451.
    PubMed         Abstract available

  6. KANTARCI K, Kapoor E, Geske JR, Castillo A, et al
    Premenopausal bilateral oophorectomy and Alzheimer's disease imaging biomarkers later in life.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14469.
    PubMed         Abstract available

  7. HAMMERS DB, Eloyan A, Thangarajah M, Taurone A, et al
    Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14218.
    PubMed         Abstract available

  8. ALMEIDA FC, Santos A, Jesus T, Coelho A, et al
    Lewy body co-pathology in Alzheimer's disease and primary age-related tauopathy contributes to differential neuropathological, cognitive, and brain atrophy patterns.
    Alzheimers Dement. 2024 Dec 22. doi: 10.1002/alz.14191.
    PubMed         Abstract available

  9. PETERSON A, Sathe A, Zaras D, Yang Y, et al
    Sex and APOE epsilon4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease.
    Alzheimers Dement. 2024 Dec 22. doi: 10.1002/alz.14343.
    PubMed         Abstract available

  10. WEINER MW, Kanoria S, Miller MJ, Aisen PS, et al
    Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials.
    Alzheimers Dement. 2024 Dec 22. doi: 10.1002/alz.14321.
    PubMed         Abstract available

  11. COLLIJ LE, Bollack A, La Joie R, Shekari M, et al
    Centiloid recommendations for clinical context-of-use from the AMYPAD consortium.
    Alzheimers Dement. 2024;20:9037-9048.
    PubMed         Abstract available

  12. LIU L, Schultz SA, Saba A, Yang HS, et al
    The pathogenicity of PSEN2 variants is tied to Abeta production and homology to PSEN1.
    Alzheimers Dement. 2024;20:8867-8877.
    PubMed         Abstract available

  13. CHONG JSX, Ji F, Hilal S, Chong JR, et al
    Additive effects of cerebrovascular disease functional connectome phenotype and plasma p-tau181 on longitudinal neurodegeneration and cognitive outcomes.
    Alzheimers Dement. 2024;20:8739-8757.
    PubMed         Abstract available

  14. NOSHENY RL, Miller M, Conti C, Flenniken D, et al
    The ADNI Administrative Core: Ensuring ADNI's success and informing future AD clinical trials.
    Alzheimers Dement. 2024;20:9004-9013.
    PubMed         Abstract available

  15. ZHANG H, Cai M, Gao F, Yang J, et al
    Thorase deficiency causes both Abeta accumulation and tau hyperphosphorylation in mouse brain.
    Alzheimers Dement. 2024;20:8769-8786.
    PubMed         Abstract available

  16. MAILLARD P, Fletcher E, Carmichael O, Schwarz C, et al
    Cerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions.
    Alzheimers Dement. 2024;20:8953-8968.
    PubMed         Abstract available

  17. WANG S, Wang Y, Xu FH, Tian X, et al
    Sex-specific topological structure associated with dementia via latent space estimation.
    Alzheimers Dement. 2024;20:8387-8401.
    PubMed         Abstract available

  18. PARK T, Hwang J, Liu S, Chaudhuri S, et al
    Genome-wide transcriptome analysis of Abeta deposition on PET in a Korean cohort.
    Alzheimers Dement. 2024;20:8787-8801.
    PubMed         Abstract available

  19. HAN F, Lee J, Chen X, Ziontz J, et al
    Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology.
    Alzheimers Dement. 2024;20:8541-8555.
    PubMed         Abstract available

  20. KISELICA AM, Hermann GE, Scullin MK, Benge JF, et al
    Technology that CARES: Enhancing dementia care through everyday technologies.
    Alzheimers Dement. 2024;20:8969-8978.
    PubMed         Abstract available

  21. KLINGER HM, Healy BC, Hanseeuw BJ, Jones RN, et al
    Latent change-on-change between amyloid accumulation and cognitive decline.
    Alzheimers Dement. 2024;20:8728-8738.
    PubMed         Abstract available

  22. MANJAVONG M, Diaz A, Ashford MT, Aaronson A, et al
    A short version of the Everyday Cognition scale can predict clinical progression and cognitive decline.
    Alzheimers Dement. 2024;20:8651-8660.
    PubMed         Abstract available

  23. WANG X, Wang X, Edland SD, Broce IJ, et al
    Enrichment for clinical trials of early AD: Combining genetic risk factors and plasma p-tau as screening instruments.
    Alzheimers Dement. 2024;20:8484-8502.
    PubMed         Abstract available

  24. GATTO RG, Hossam Y, Reichard RR, Lowe VJ, et al
    Microscopy assessment of a fluorescence [(18)F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions.
    Alzheimers Dement. 2024;20:8758-8768.
    PubMed         Abstract available

  25. PROSSER L, Sudre CH, Oxtoby NP, Young AL, et al
    Biomarker pathway heterogeneity of amyloid-positive individuals.
    Alzheimers Dement. 2024;20:8503-8515.
    PubMed         Abstract available

  26. REAS ET, Solders SK, Tsiknia A, Triebswetter C, et al
    APOE ?4-related blood-brain barrier breakdown is associated with microstructural abnormalities.
    Alzheimers Dement. 2024;20:8615-8624.
    PubMed         Abstract available

  27. WATTS A, Szabo-Reed A, Baker J, Morris JK, et al
    LEAP! Rx: A randomized trial of a pragmatic approach to lifestyle medicine.
    Alzheimers Dement. 2024;20:8374-8386.
    PubMed         Abstract available

  28. WOODWORTH DC, Nguyen KM, Sordo L, Scambray KA, et al
    Evaluating the updated LATE-NC staging criteria using data from NACC.
    Alzheimers Dement. 2024;20:8359-8373.
    PubMed         Abstract available

  29. KNOPMAN DS
    Precision diagnosis of cognitive impairment due to Alzheimer's disease for therapeutic interventions.
    Alzheimers Dement. 2024 Dec 24. doi: 10.1002/alz.14043.
    PubMed         Abstract available

  30. DICKERSON BC, Atri A, Clevenger C, Karlawish J, et al
    The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14337.
    PubMed         Abstract available

  31. ATRI A, Dickerson BC, Clevenger C, Karlawish J, et al
    Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14333.
    PubMed         Abstract available

  32. ATRI A, Dickerson BC, Clevenger C, Karlawish J, et al
    The Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders (DETeCD-ADRD): Validated clinical assessment instruments.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14335.
    PubMed         Abstract available

  33. KULMINSKI AM, Jain-Washburn E, Nazarian A, Wilkins HM, et al
    Association of APOE alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease neuroimaging markers.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14445.
    PubMed         Abstract available

  34. CAO J, Zhang C, Lo CZ, Guo Q, et al
    Integrating rare pathogenic variant prioritization with gene-based association analysis to identify novel genes and relevant multimodal traits for Alzheimer's disease.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14444.
    PubMed         Abstract available

  35. TRELLE AN, Young CB, Vossler H, Ramos Benitez J, et al
    Plasma Abeta(42)/Abeta(40) is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14442.
    PubMed         Abstract available

  36. HAMMERS DB, Eloyan A, Taurone A, Thangarajah M, et al
    Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14439.
    PubMed         Abstract available

  37. SAMSTAG CL, Chapman NH, Gibbons LE, Geller J, et al
    Neuropathological correlates of vulnerability and resilience in the cerebellum in Alzheimer's disease.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14428.
    PubMed         Abstract available

  38. ZELLMER JC, Tarantino MB, Kim M, Lomoio S, et al
    Stabilization of mitochondria-associated endoplasmic reticulum membranes regulates Abeta generation in a three-dimensional neural model of Alzheimer's disease.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14417.
    PubMed         Abstract available

  39. CANAL-GARCIA A, Branca RM, Francis PT, Ballard C, et al
    Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis.
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14375.
    PubMed         Abstract available

  40. KLOSKE CM, Forner S, Meyers EA, Towers AE, et al
    Alzheimer's Association's funding portfolio: Insights from the International Alzheimer's and Related Dementias Research Portfolio (IADRP).
    Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14354.
    PubMed         Abstract available


    Biol Psychiatry

  41. ZHAO K, Chen P, Wang D, Zhou R, et al
    A Multiform Heterogeneity Framework for Alzheimer's Disease Based on Multimodal Neuroimaging.
    Biol Psychiatry. 2024 Dec 24:S0006-3223(24)01817.
    PubMed         Abstract available


    BMC Neurol

  42. QIAO M, Wu H, Chi L, Yao Q, et al
    A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease: a case report.
    BMC Neurol. 2024;24:489.
    PubMed         Abstract available


    Brain Res

  43. YANG Q, Chen T, Li S, Yang C, et al
    Inhibition of autophagy attenuates cognitive decline and mitochondrial dysfunction in an Alzheimer's disease mouse model with chronic cerebral hypoperfusion.
    Brain Res. 2024;1850:149416.
    PubMed         Abstract available


    Curr Alzheimer Res

  44. BHATTACHARYA K, Sungoh D, Kharmujai D, Islam A, et al
    Exploring the Therapeutic Potential of 8-Prenyldaidzein: A Comprehensive Study of its Multi-Target Efficacy in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050358848241211080546.
    PubMed         Abstract available

  45. LIN F, Yang X, Li L, Chen J, et al
    The Relationship between Alzheimer's Disease and Ferroptosis: A Bibliometric Study Based on Citespace.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050348799241211072746.
    PubMed         Abstract available

  46. BOLSHAKOVA OI, Slobodina AD, Slepneva EE, Sarantseva SV, et al
    Acetyl-L-Carnitine Aids in Preservation of Cholinergic Neurons and Memory in the Drosophila melanogaster Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050347906241203075930.
    PubMed         Abstract available

  47. WU D, Zhang B, Chang Y, Huang S, et al
    Apathy Associated with Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050350970241216072400.
    PubMed         Abstract available

  48. MISHRA AK, Srivastava A, Raj V, Saini V, et al
    Recent Updates on Alzheimer's Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease.
    Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050361294241211071813.
    PubMed         Abstract available


    J Alzheimers Dis

  49. BENNETT CG, Guttmann RP, Hackney ME, Amin R, et al
    Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease.
    J Alzheimers Dis. 2024 Dec 23:13872877241298529. doi: 10.1177/13872877241298529.
    PubMed         Abstract available

  50. HORSTKOTTER D
    Alzheimer's disease prediction and prevention in a public health perspective: Ethical considerations and collaborations beyond the biomedical paradigm.
    J Alzheimers Dis. 2024 Dec 23:13872877241308299. doi: 10.1177/13872877241308299.
    PubMed         Abstract available

  51. GAN J, Zeng Y, Huang G, Wang XD, et al
    The updated prevalence and risk factors of dementia in old adults in China: A cross-sectional study.
    J Alzheimers Dis. 2024;102:1209-1223.
    PubMed         Abstract available


    J Neurochem

  52. WANG YC, Huang LY, Guo HH, Liu M, et al
    Higher CSF sTREM2 attenuates APOE epsilon4-related risk for amyloid pathology in cognitively intact adults: The CABLE study.
    J Neurochem. 2025;169:e16273.
    PubMed         Abstract available


    J Neurosci


  53. Erratum: Tosi et al., "The Network Structure of Cognitive Impairment: From Subjective Cognitive Decline to Alzheimer's Disease".
    J Neurosci. 2024 Dec 23:e2082242024. doi: 10.1523/JNEUROSCI.2082-24.2024.
    PubMed        


    Neurol Clin Pract

  54. SEABURY J, Weinstein J, Varma A, Rosero SJ, et al
    Patient- and Caregiver-Reported Impact of Symptoms in Alzheimer Disease, Mild Cognitive Impairment, and Dementia.
    Neurol Clin Pract. 2025;15:e200418.
    PubMed         Abstract available


    Neurology

  55. QUISPIALAYA KM, Therriault J, Aliaga A, Benedet AL, et al
    Comparison of Plasma p-tau217 and [(18)F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia.
    Neurology. 2025;104:e210211.
    PubMed         Abstract available


    PLoS One

  56. LEE GB, Jeong YJ, Kang DY, Yun HJ, et al
    Multimodal feature fusion-based graph convolutional networks for Alzheimer's disease stage classification using F-18 florbetaben brain PET images and clinical indicators.
    PLoS One. 2024;19:e0315809.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.